LabMed

Increased PTT Only: A Prolonged PTT with a Normal PT

Differential Diagnosis

Heparin in the specimen, which may be a result of heparin treatment of the patient

Treatment with low molecular weight heparin, argatroban, or lepirudin

A lupus anticoagulant (i.e., lupus inhibitor)

Deficiency of factor VIII (hemophilia A) or IX (hemophilia B)

Deficiency of factor VIII (mild or severe) associated with von Willebrand's disease

Deficiency of factor XI, XII, or prekallikrein (Fletcher factor)

An inhibitor to factor VIII or IX

Suggested Additional Lab Testing

If heparin contamination in the sample is a possibility, ask for a repeat PTT or, if necessary, get a heparin measurement.

To help differentiate between coagulation inhibitors and factor deficiencies, perform PTT mixing studies (patient plasma plus normal plasma in equal volumes).

A patient positive for the lupus anticoagulant should have at least one positive lupus anticoagulant screening test and at least one positive confirmatory test that involves detection of phospholipid neutralization by the lupus anticoagulant.

Factor assays for factors VIII, IX, XI XII, and, in rare circumstances, an assay for prekallikrein (Fletcher factor) can determine if a deficiency in one or more of these factors explains the prolonged PTT.

Bethesda Unit assay is used to quantitate the amount of antibody to factor VIII in a patient with a PTT mixing study result suggestive of a factor VIII inhibitor. An evaluation for von Willebrand includes factor VIII, von Willebrand factor, and ristocetin cofactor. The factor VIII in von Willebrand patients may not be low enough to prolong the PTT.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs